MetLife Investment Management, LLC - CO-DIAGNOSTICS INC ownership

CO-DIAGNOSTICS INC's ticker is CODX and the CUSIP is 189763105. A total of 85 filers reported holding CO-DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CO-DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$28,200
-75.3%
2,956
-76.0%
0.00%
-100.0%
Q4 2020$114,316
-31.6%
12,2920.0%0.00%
-50.0%
Q3 2020$167,048
-29.8%
12,2920.0%0.00%
-33.3%
Q2 2020$237,85012,2920.00%
Other shareholders
CO-DIAGNOSTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Advisor Resource Council 263,358$1,628,0000.49%
SummerHaven Investment Management, LLC 114,800$709,0000.40%
Prairiewood Capital, LLC 59,145$366,0000.26%
Aristides Capital LLC 60,000$371,0000.23%
EASTERLY INVESTMENT PARTNERS LLC 142,190$879,0000.07%
AXS Investments LLC 24,980$154,0000.06%
Physician Wealth Advisors, Inc. 40,375$188,0000.05%
HUSSMAN STRATEGIC ADVISORS, INC. 36,000$222,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,800$1,742,0000.03%
SUMMIT WEALTH & RETIREMENT PLANNING, INC. 14,248$88,0000.03%
View complete list of CO-DIAGNOSTICS INC shareholders